大肠杆菌精氨酰—tRNA合成酶的Lys306为酶活力所必需

将大肠杆菌精氨酰ｔＲＮＡ合成酶（ＡｒｇＲＳ）上Ｌｙｓ３０６用基因点突变的方法分别变为Ａｌａ和Ａｒｇ的密码子,得到变种基因ａｒｇｓ３０６ＫＡ和ａｒｇｓ３０６ＫＲ。变种基因重组在ｐＵＣ１８上,转化到大肠杆菌ＴＧ１中,转化子中ＡｒｇＲＳ及其变种ＡｒｇＲＳ３０６ＫＡ和ＡｒｇＲＳ３０６ＫＲ所表达的蛋白量生活为ＴＧ１表达ＡｒｇＲＳ蛋白量的１００倍。细胞粗抽提液中ＡｒｇＲＳ的比活ＴＧ１,转化子ｐＵＣ１８－ａｒｇ     

大肠杆菌精氨酰－tRNA合成酶的Lys306为酶活力所必需

将大肠杆菌精氨酰ｔＲＮＡ合成酶（ＡｒｇＲＳ）上Ｌｙｓ３０６用基因点突变的方法分别变为Ａｌａ和Ａｒｇ的密码子;得到变种基因ａｒｇｓ３０６ＫＡ和ａｒｇｓ３０６ＫＲ。变种基因重组在ｐＵＣ１８上,转化到大肠杆菌ＴＧ１中,转化子中ＡｒｇＲＳ及其变种ＡｒｇＲＳ３０６ＫＡ和ＡｒｇＲＳ３０６ＫＲ所表达的蛋白量至少为ＴＧ１表达ＡｒｇＲＳ蛋白量的１００倍。细胞粗抽提液中ＡｒｇＲＳ的比活ＴＧ１、转化子ｐＵＣ１８－ａｒｇｓ、ｐＵＣ１８－ａｒｇｓ３０６ＫＡ和ｐＵＣ１８－ａｒｇｓ３０６ＫＲ分别为１．６５、２１０、１．８和３８单位／毫克。结果表明ＡｒｓＲＳ的Ｌｙｓ３０６为Ａｌａ取代使活力完全丧失;若被Ａｒｇ取代,则活力丧失８０％以上。Ｌｙｓ３０６为ＡｒｇＲＳ活力所必需。     

大肠杆菌精氨酰－tRNA合成酶的Lys378和381的点突变研究

用点突变的方法将大肠杆菌精氨酰—ｔＲＮＡ合成酶（ＡｒｇＲＳ）的基因ａｒｇｓ上相应于Ｌｙｓ３７８和Ｌｙｓ３８１的密码ＡＡＡ分别变为两氨酸的密码ＧＣＡ和精氨酸的密码子ＣＧＴ,得到了４个ａｒｇｓ的突变体ａｒｇｓ３７８ＫＡ,ａｒｇｓ３７８ＫＲ,ａｒｇｓ３８１ＫＡ和ａｒｇｓ３８１ＫＲ,将它们分别连接到ｐＵＣ１８上,转入大肠杆菌ＴＧ１,在ＴＧ１转化子中,ＡｒｇＲＳ及其变种的表达量约为ＴＧ１中的１２０倍以上。结果表明Ｌｙｓ３７８为Ａｒｇ和Ａｌａ取代分别使活力下降０％和１０％;Ｌｙｓ３８１变为Ａｌａ和Ａｒｇ后,活力分别下降３３％和１０％左右。Ｌｙｓ３７８不为酶活力必需。Ｌｙｓ３８１部位的正电荷对酶活力是重要的。     

组织型纤溶酶原激活剂A链与尿激酶原B链嵌合分子的构建与表达

利用 Ｄ Ｎ Ａ 重组技术和定位删除技术,将组织型纤溶酶原激活剂（ｔ Ｐ Ａ）的 Ａ 链（ Ｓｅｒｌ Ｔｈｒ２６３）基因与尿激酶原（ｐｒｏ Ｕ Ｋ）的 Ｂ链（ Ｓｅｒ１３８ Ｌｅｕ４１１）基因相连,得到嵌合分子基因ｔｕ ｐａ,并在昆虫杆状病毒系统中进行表达,表达量可达 ５００ Ｉ Ｕ／ｍ ｌ．经单克隆抗体免疫亲和层析纯化细胞表达上清液,得到ｔｕ Ｐ Ａ 嵌合分子,其比活为 ２００ ０００ Ｉ Ｕ／ｍ ｇ 蛋白． Ｓ Ｄ Ｓ Ｐ Ａ Ｇ Ｅ 及 Ｗ ｅｓｔｅｒｎ ｂｌｏｔ 鉴定证明此表达产物分子量约为 ６０ ｋ Ｄ,与预期值相符．纤维蛋白平板测活及纤维蛋白亲和性分析初步证明,此嵌合分子的溶纤活性与ｐｒｏ Ｕ Ｋ 相近,而纤维蛋白亲和性高于 ｐｒｏ Ｕ Ｋ．     

重组人尿激酶原的分离纯化及性质研究

本文报道从人尿激酶原（ｐｒｏ－ｕｒｏｋｉｎａｓｅ,ｐｒｏ－ＵＫ）基因重组工程菌Ｅ．ｃｏｌｉＪＡ２２１表达产物的复性液中纯化尿激酶原的方法。复性产物经Ｚｎ＾２＋选择性沉淀,尿激酶抗体亲和柱层析,ｂｅｎｚａｍｉｄｉｎｅ－Ｓｅｐｈａｒｏｓｅ ＣＬ ４Ｂ亲和吸附,即得比活达１１００００ＩＵ／ｍｇ的纯化产品。样品经ＳＤＳ－ＰＡＧＥ鉴定,在还原及非还原条件下,均表现为分子量为４３ｋｄ的单一条带。动力学研究测得     

人尿激酶原cDNA在昆虫杆状病毒真核表达系统中的高效表达

人尿激酶原是一种新型溶栓剂,优于尿激酶,具有血纤维蛋白特异性,为了在昆虫杆状病毒表达系统中高效表达ｐｒｏ－ＵＫ,我们在ｐＡｃ３７３基础上,插入野生型ＡｃＭＮＰＶ ｐｏｌｙｈｅｄｒｉｎ启动子区－７～－１碱基序列,构建了一个高表达转移载体ｐＡｃＹＴ．分别经三次克隆将ｐｒｏ－ＵＫ ｃＤＮＡ正向插入到转移载体ｐＡｃ３７３或ｐＡｃＹＴ的ＢａｍＨＩ－ＫｐｎＩ位点上。用Ｌｉｐｏｆｅｃｔｉｎ将ｐＡｃＹＴ－ＵＫＤＮ     

编码大肠杆菌精氨酰—tRNA合成酶的基因（argS）拥？…

编码大肠杆菌（Ｅ．ｃｏｌｉ）精氨酰－ｔＲＮＡ合成酶（ＡｒｇＲＳ）的基因（ａｒｇＳ）和编码亮氨酰－ｔＲＮＡ合成酶（ＬｅｕＲＳ）的基因（ＬｅｕＳ）分别插入ｐＵＣ１８后,各自在Ｅ．ｃｏｌｉ ＴＧ１转化子中的表达有很大的差异（高表达倍数分别为１０００和３５倍）。为了调查造成其表达差异的原因,用ａｒｇＳ的５＇上游非编码区取代ｌｅｕＳ的５＇上游非编码区,构建了融合基因ｐａｒｇ－ｌｅｕＳ;将它插入质粒ｐＵＣ１８     

u-PA/t-PA嵌合型纤溶酶原激活剂(ut-PA)的构建、表达、纯化和性质研究

将尿激酶原（ｐｒｏ－ＵＫ）ｃＤＮＡ和组织型纤溶酶原激活剂（ｔ－ＰＡ）Ａ链ｃＤＮＡ克隆到Ｍ１３ｍｐ１８中,经过二次寡核甘酸诱导的大片段定点删除和一次寡核苷酸诱导的多位点突变,得到ｕ－ＰＡ（Ｌｅｕ１４４－Ｇｌｙ４０８）／ｔ－ＰＡ（Ｓｅｒ１－Ｔｈｒ２６３）（ｕｔ－ＰＡ）融合基因．将ｕｔ－ＰＡ融合基因克隆到表达载体ｐＣＭ－βｎｅｏ中,与ｐＣＭ－ｄｈｆｒ共转染ＣＨＯ／ＤＨＦＲ－细胞,筛选稳定表达株．收集无血清表达上清,经苯甲脒柱纯化得到ｕｔ－ＰＡ纯品,ＳＤＳ－ＰＡＧＥ和纤维蛋白自显影显示ｕｔ－ＰＡ有两种分子量形式,分子量分别为６８ｋＤ和６１ｋＤ．纤维蛋白亲和性试验表明,ＬＵＫ（低分子量尿激酶）对纤维蛋白没有亲和性,而含有ＬＵＫ的ｕｔ－ＰＡ则对纤维蛋白表现出很强的亲和性,但ｕｔ－ＰＡ的亲和性略低于亲本ｔ－ＰＡ．     

大肠杆菌精氨酰—tRNA合成酶的变种ArgRS306KR的纯化…

本文从含ＡｒｇＲＳ３０６ＫＲ基因ａｒｇｓ３０６ＫＲ的ｐＵＣ１８重组质粒的大肠杆菌ＴＧ１转化子中经ＤＥＡＥ－Ｓｅｐｈａｃｅｌ和Ｂｌｕｅ－Ｓｅｐｈａｒｏｓｅ两步柱层析,得到电泳一条带的ＡｒｇＲＳ３０６ＫＲ。纯酶的比活为２７９０单位／毫克。该酶氨酰化和ＡＴＰ－ＰＰｉ交换活力的最适ＰＨ分别为ＰＨ８．３和ＰＨ７．５。氨酰化活力对ＡＴＰ、Ａｒｇ和ｔＲＮＡ的Ｋｍ分别２．６ｍｍｏｌ／Ｌ、１４．０μｍｏｌ／Ｌ和５．     

解偶联蛋白基因-3826多态性与其mRNA表达相关性的研究

为了探讨解偶联蛋白（ＵＣＰ）基因－３８２６多态性与ＵＣＰｍＲＮＡ表达水平之间可能存在的联系,应用ＲＴ－ＰＣＲ方法测定了ＵＣＰ基因－３８２６多态性野生型（ＡＡ）,杂合子（ＡＧ）和突变纯合子（ＧＧ）３组人群脂肪组织中ＵＣＰｍＲＮＡ的表达水平．定量结果指出：３种基因型（ＡＡ、ＡＧ和ＧＧ）携带者腹膜内脂肪的ＵＣＰｍＲＮＡ表达水平存在极显著差异（Ｐ＜０．０１）,并显示突变等位基因（Ｇ）的数量与ＵＣＰｍＲＮＡ表达水平呈负相关．此结果表明ＵＣＰ基因Ａ→Ｇ（－３８２６）变异与ＵＣＰｍＲＮＡ表达水平降低密切相关．但该变异导致ＵＣＰｍＲＮＡ表达水平降低的机制还有待进一步研究     

The expression of proUK in Escherichia coli: the vgb promoter replaces IPTG and coexpression of argU compensates for rare codons in a hypoxic induction model

The expression of the proUK gene was improved by the coexpression of the argU gene cloned in a moderate copy number vector. As the proUK gene contains 2% AGG/AGA codons, which is much higher than the normal frequency in E. coli, about 0.14%-0.21%, the argU gene cloned in a multicopy plasmid was coexpressed with the proUK expression vector in our experiments. In E. coli strain BL21(DE3), IPTG is known to induce the expression of T7 RNA polymerase gene and this enzyme can transcribe the proUK gene under the control of the T7 promoter leading to expression of proUK. To replace IPTG by a cheaper alternative on a large scale, we constructed a plasmid in which the vgb promoter--which is known to be activated by the onset of hypoxic conditions--controls the T7RNA polymerase gene expression. Low oxygen conditions were then used to activate the vgb promoter causing T7RNA polymerase gene expression and finally leading to the expression of proUK as inactive inclusion bodies. Our experiments on a large scale in a bioreactor show that the expression of proUK accounts for about 30% of total protein after about 6 h of anaerobic cultivation, so the presented model represents an economical alternative to IPTG induction.     

Frameshift suppression at tandem AGA and AGG codons by cloned tRNA genes: assigning a codon to argU tRNA and T4 tRNA(Arg).

Arginine is coded for by CGN (N = G, A, U, C), AGA and AGG. In Escherichia coli there is little tRNA for AGA and AGG and the use of these codons is strongly avoided in virtually all genes. Recently, we demonstrated that the presence of tandem AGA or AGG codons in mRNA causes frameshifts with high frequency. Here, we show that phaseshifts can be suppressed when cells are transformed with the gene for tRNA(T4Arg) or E. coli tRNA(argU,Arg) demonstrating that such errors are the result of tRNA depletion. Bacteriophage T4 encoded tRNA(Arg) (anticodon UCU) corrects shifts at AGA-AGA but not at AGG-AGG, suggesting that this tRNA can only read AGA. Similarly, comparison of the translational efficiencies in an argU (Ts) mutant and in its isogenic wild type parent indicates that argU tRNA (anticodon UCU) reads AGA but not AGG. An argU (Ts) mutant barely reads through AGA-AGA at 42 degrees C but translation of AGG-AGG is hardly, if at all, affected. Overexpression of argU+ relaxes the codon specificity. The thermosensitive mutant in argU, previously called dnaY because it is defective in DNA replication, can be complemented for growth by the gene for tRNA(T4Arg). This implies that the sole function of the argU gene product is to sustain protein synthesis and that its role in replication is probably indirect.     

The Escherichia coli argU10(Ts) phenotype is caused by a reduction in the cellular level of the argU tRNA for the rare codons AGA and AGG

The Escherichia coli argU10(Ts) mutation in the argU gene, encoding the minor tRNA(Arg) species for the rare codons AGA and AGG, causes pleiotropic defects, including growth inhibition at high temperatures, as well as the Pin phenotype at 30 degrees C. In the present study, we first showed that the codon selectivity and the arginine-accepting activity of the argU tRNA are both essential for complementing the temperature-sensitive growth, indicating that this defect is caused at the level of translation. An in vitro analysis of the effects of the argU10(Ts) mutation on tRNA functions revealed that the affinity with elongation factor Tu-GTP of the argU10(Ts) mutant tRNA is impaired at 30 and 43 degrees C, and this defect is more serious at the higher temperature. The arginine acceptance is also impaired significantly but to similar extents at the two temperatures. An in vivo analysis of aminoacylation levels showed that 30% of the argU10(Ts) tRNA molecules in the mutant cells are actually deacylated at 30 degrees C, while most of the argU tRNA molecules in the wild-type cells are aminoacylated. Furthermore, the cellular level of this mutant tRNA is one-tenth that of the wild-type argU tRNA. At 43 degrees C, the cellular level of the argU10(Ts) tRNA is further reduced to a trace amount, while neither the cellular abundance nor the aminoacylation level of the wild-type argU tRNA changes. We concluded that the phenotypic properties of the argU10(Ts) mutant result from these reduced intracellular levels of the tRNA, which are probably caused by the defective interactions with elongation factor Tu and arginyl-tRNA synthetase.     

Characterization of the cryptic lambdoid prophage DLP12 of Escherichia coli and overlap of the DLP12 integrase gene with the tRNA gene argU.

The argU (dnaY) gene of Escherichia coli is located, in clockwise orientation, at 577.5 kilobases (kb) on the chromosome physical map. There was a cryptic prophage spanning the 2 kb immediately downstream of argU that consisted of sequences similar to the phage P22 int gene, a portion of the P22 xis gene, and portions of the exo, P, and ren genes of bacteriophage lambda. This cryptic prophage was designated DLP12, for defective lambdoid prophage at 12 min. Immediately clockwise of DLP12 was the IS3 alpha 4 beta 4 insertion element. The argU and DLP12 int genes overlapped at their 3' ends, and argU contained sequence homologous to a portion of the phage P22 attP site. Additional homologies to lambdoid phages were found in the 25 kb clockwise of argU. These included the cryptic prophage qsr' (P. J. Highton, Y. Chang, W. R. Marcotte, Jr., and C. A. Schnaitman, J. Bacteriol. 162:256-262, 1985), a sequence homologous to a portion of lambda orf-194, and an attR homolog. Inasmuch as the DLP12 att int xis exo P/ren region, the qsr' region, and homologs of orf-194 and attR were arranged in the same order and orientation as the lambdoid prophage counterparts, we propose that the designation DLP12 be applied to all these sequences. This organization of the DLP12 sequences and the presence of the argU/DLP12 int pair in several E. coli strains and closely related species suggest that DLP12 might be an ancestral lambdoid prophage. Moreover, the presence of similar sequences at the junctions of DLP12 segments and their phage counterparts suggests that a common mechanism could have transferred these DLP12 segments to more recent phages.     

A minor arginine tRNA mutant limits translation preferentially of a protein dependent on the cognate codon.

The Escherichia coli argU gene encodes a rare arginine tRNA (anticodon UCU) that translates the similarly rare AGA codon. The argU10(Ts) mutation is a transition that changes the first nucleotide of the mature tRNA from G to A, presumably destabilizing the acceptor stem. This mutation, when present in haploid condition in the chromosome, reduces the growth rate at 30 degrees C and results in cessation of growth after 60 to 90 min at 43 degrees C. The mutation also preferentially limits (compared with total protein synthesis) translation of an induced gene that depends on five AGA codons, i.e., the lambda cI repressor gene. Translation of another inducible protein, beta-galactosidase, which does not involve AGA codons, was inhibited to a much lesser extent. The chromosomal argU(Ts) mutation also confers the Pin phenotype, that is, loss of ability of the host, as a P2 lysogen, to inhibit growth of bacteriophage lambda, probably the result of reduced translation of the P2 old gene, which contains five AGA codons (E. Hagg?rd-Ljungquist, V. Barreiro, R. Calendar, D. M. Kurnit, and H. Cheng, Gene 85:25-33, 1989).     

RGD多肽与尿激酶原嵌合分子的构建及性质研究

利用定点突变及DNA重组技术 ,将编码RGD多肽 (GPRGDWRMLG)的双链DNA片段 ,定向插入到相对于编码尿激酶原的Gly118 Leu119的cDNA分子中 ,构建了尿激酶原的嵌合体基因 ,并在甲醇酵母表达系统中进行了分泌表达。经过Zn²⁺ 螯合柱及SP阳离子柱两步层析后 ,目的蛋白质被纯化。经纤维蛋白平板测活 ,嵌合分子的比活为 6 5 0 0 0IU mg。嵌合分子与尿激酶相比 ,对显色底物S2 44 4作用的催化效率偏低 ,但具有较强的抑制血小板聚集的功能 ,抑制常数IC5 0为 2 1μmol L。以上结果表明嵌合分子不但具有较强的溶栓功能 ,而且具有抗栓功能 ,很可能是一种具有发展前景的双功能溶栓 抗栓分子     

The Salmonella typhimurium uracil-sensitive mutation use is in argU and encodes a minor arginine tRNA.

The use gene of Salmonella typhimurium was previously identified by a mutation conferring sensitivity to uracil in glucose minimal medium. The use gene was cloned and identified as an allele of argU encoding a tRNA for a minor arginine codon (CGG). The uracil-sensitive phenotype was shown to result from a base substitution in the anticodon stem of this tRNA.     

A prourokinase-RGDS chimera——Construction, expression and characterization

A tetrapeptide, RGDS, was inserted into proUK kringle domain G118-L119 by the construction of a mutant proUK-RGDS gene. The gene was expressed in the baculovirus expression system. Immunoaffinity chromatography was used to purify the chimera and protein with purity over 90% was achieved. The chimera was tested for its platelet membrane binding function and showed a calcium-dependent platelet binding activity. Amidolytic activity of the chimera was tested. The result indicated that specific amidolytic activity of plasmin activated chimera was 62000 IU/mg, comparable to the previously reported 65 355 IU/mg of plasmin activated natural proUK. Activation of plasminogen by the chimera after plasmin treatment followed Micbieal-Menten kinetics, and the Km was 0.97 μmol/L, which was also comparable to 1.64 μmol/L of native urokinase. The chimera also showed intensive ability to inhibit platelet aggregation in vitro. These results indicate that this chimera might be useful as a bifunctional thrombolytic agent.